Biomedical Engineering Reference
In-Depth Information
therapeutic nucleosidase hydrolase in functionalised nanocapsules', J Control Rel,
102, 171±179.
Ichikawa K, Hikita T, Maeda N, Yonezawa S, Takeuchi Y, Asai T, Namba Y and Oku N
(2005), `Antiangiogenic photodynamic therapy (PDT) by using long-circulating
liposomes modified with peptide specific to angiogenic vessels', Biochim Biophys
Acta, 1669, 69±74.
Ishida O, Maruyama K, Yanagie H, Eriguchi M and Iwatsuru M (2000), `Targeting
chemotherapy to solid tumors with long-circulating thermosensitive liposomes and
local hyperthermia', Jpn J Cancer Res, 91, 118±126.
Ishida O, Maruyama K, Tanahashi H, Iwatsuru M, Sasaki K, Eriguchi M and Yanagie H
(2001), `Liposomes bearing polyethyleneglycol-coupled transferrin with intra-
cellular targeting property to the solid tumors in vivo', Pharm Res, 18, 1042±1048.
Ito A, Shinkai M, Honda H and Kobayashi T (2005), `Medical application of
functionalized magnetic nanoparticles', J Biosci Bioeng, 100 (1), 1±11.
Jain R K (1987), `Transport of molecules across tumor vasculature', Cancer Metastasis
Rev, 6, 559±593.
Jeon S I, Lee J H, Andrade J D and De Gennes P G (1991), `Protein-surface interactions
in the presence of polyethylene oxide; 1. Simplified theory', J Colloid Interf Sci,
142, 149±166.
Juliano R L (1988), `Factors affecting the clearance kinetics and tissue distribution of
liposomes, microspheres and emulsions', Adv Drug Deliv Rev, 2, 31±54.
Kamps J A A M, Morselt H W M, Swart P J, Meijer D K F and Scherphof G L (1997),
`Massive targeting of liposomes, surface modified with anionized albumins, to
hepatic endothelial cells', Proc Natl Acad Sci USA, 94, 11681±11685.
Kaur I P, Garg A, Singla A K and Aggarwal D (2004), `Vesicular systems in ocular drug
delivery: an overview', Int J Pharm 269, 1±14.
Kedar E, Gur H, Babai I, Samira S, Even-Chen S and Barenholz Y (2000), `Delivery of
cytokines by liposomes. Hematopoietic and immunomodulatory activity of
interleukin-2 encapsulated in conventional
liposomes and long-circulating
liposomes', J Immunother, 23, 131±145.
Kersten G F A and Crommelin D J A (2003), `Liposomes and ISCOMs', Vaccine, 21,
915±920.
Kessner S, Krause A, Rothe U and Bendas G (2001), `Investigation of the cellular uptake
of E-selectin-targeted immunoliposomes by activated human endothelial cells',
Biochim Biophys Acta, 1514, 177±190.
Khaw B A, Torchilin V P, Vural I and Narula J (1995), `Plug and seal: prevention of
hypoxic cardiocyte death by sealing membrane lesions with antimyosin-liposomes',
Nature Med, 1, 1195±1198.
Koning G A, Kamps J A and Scherphof G L (2002), `Efficent intracellular delivery of 5-
fluorodeoxyuridine into colon cancer cells by targeted immunoliposomes', Cancer
Detect Prevent, 26 (4), 299±307.
Konno H, Tadakuma T, Kumai K, Takahashi T, Ishibiki K, Abe O and Sagaguchi S
(1990), `The antitumor effects of adriamycin entrapped in liposomes on lymph node
metastases', Jpn J Surg, 20, 424±428.
Kullberg M, Mann K and Owens J L (2005), `Improved drug delivery to cancer cells: a
method using magnetoliposomes that target epidermal growth factor receptors',
Medical Hypotheses, 64, 468±470.
Landen C N Jr, Chavez-Reyes A, Bucana C, Schmandt R, Deavers M T, Lopez-Berestein
G and Sood A K (2005), `Therapeutic EphA2 gene targeting in vivo using neutral
liposomal small interfering RNA delivery', Cancer Res, 65 (15), 6910±6918.
Search WWH ::
Custom Search